Dacuronium bromide
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | NB-68; 17β-Hydroxypancuronium bromide; 3α-(Acetyloxy)-17β-hydroxy-2β,16β-bis(1-methylpiperidinium-1-yl)-5α-androstane dibromide; 2β,16β-Dipiperidino-5α-androstane-3α,17β-diol 3α-acetate dimethobromide |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.043.834 |
| Chemical and physical data | |
| Formula | C33H58Br2N2O3 |
| Molar mass | 690.646 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Dacuronium bromide (INN, BAN) (developmental code name NB-68) is an aminosteroid neuromuscular blocking agent which was never marketed. It acts as a competitive antagonist of the nicotinic acetylcholine receptor (nAChR).
| nAChRs |
|
||||
|---|---|---|---|---|---|
|
Precursors (and prodrugs) |
|||||